General Medicine raises $120M to bring healthcare into one storefront

Why it matters

The $120M round supports General Medicine's plan to bring prescriptions, tests, imaging and other care into one storefront, extending the healthcare access problem Parker worked on at PillPack beyond pharmacy.

General Medicine raised $120 million in a Series B led by Andreessen Horowitz on October 6th, 2026, as co-founder TJ Parker took the CEO role full time. General Medicine is trying to make finding, pricing and arranging care one connected task instead of a string of calls, portals and referrals, according to the investment announcement.

For Parker, the move brings him back from venture investing to operating General Medicine. He was a general partner at Matrix, where he led General Medicine's early funding, and remains a venture partner there, according to General Medicine. He previously co-founded PillPack, the online pharmacy Amazon acquired in 2018, and later worked on Amazon Pharmacy and Amazon Clinic. At PillPack, he raised more than $100 million and grew the company to more than 1,000 employees, according to Parker's biography.

The Series B brings General Medicine's reported total funding to $152 million. Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup also participated, according to General Medicine's financing announcement. General Medicine's announcement says the new capital will expand its store into more categories of care.

The problem is the handoff

Parker and co-founder Elliot Cohen have built around a familiar frustration: knowing what care might help does not make it easy to get. A patient may need a prescription renewal, a lab test or an imaging appointment, then still have to find a provider, check coverage, retrieve records, arrange a referral and work out the price.

Cohen's earlier work on PillPack grew from a personal experience. His father struggled to manage medication after quadruple-bypass surgery; Cohen later said that watching him spill pills while sorting them into a weekly organizer helped convince him there had to be a better way. At MIT, Cohen helped create the Hacking Medicine program and met Parker through the university's entrepreneurship community. Their first company focused on medication management. General Medicine takes the same consumer-centered instinct into the steps surrounding care, though General Medicine has not attributed its founding to that specific family experience.

General Medicine combines its own medical group with a marketplace of outside clinicians. Patients can browse medications, labs, imaging, specialist consultations and selected in-person care, while bringing their health history and insurance details into the same experience. General Medicine says its catalog contains more than 2,900 products and services. Its AI chat can help users explore symptoms and options, while licensed clinicians determine what's clinically appropriate when review is required.

The catalog and its underlying connections are less visible than a chatbot. General Medicine needs them to turn advice into an appointment instead of another list of tasks. A lab test or imaging service can be described differently by a patient, a provider, an insurer or a lab. General Medicine says it has built a shared catalog to match those descriptions and present options and prices.

A founder returns to the operating job

Parker is CEO; founding CEO Ashwin Muralidharan moved into the chief product officer role, and Cohen is president. Muralidharan continues to lead product, engineering, design, clinical and operations work, according to General Medicine. The leadership change puts Parker, whose prior company was built around making a complicated healthcare transaction easier to complete, in charge of scaling a broader access platform.

General Medicine is building both a direct-to-consumer storefront and infrastructure it says could serve health systems, insurers, pharmacies and other healthcare organizations. The a16z announcement describes enterprise partnerships as a potential extension of the same pricing, clinical guidance and access tools. That is a strategic prospect, not evidence of signed enterprise customers.

General Medicine says hundreds of thousands of people have signed up since its nationwide launch in May 2025 and reports an average net promoter score of 80. It also says 83% of customers addressed a health need they had delayed, with one-third having postponed care for more than six months. Those figures are company-reported; the announcement does not provide survey methods or independent verification. They show the customer problem General Medicine says it is addressing, while leaving open how often users return and how much care they complete through the service.

General Medicine's premise is that a broad storefront can keep patients from dropping out between a recommendation and the actual care. For that to work, prices have to be useful, records have to travel across providers, and outside clinicians need to be bookable when a patient needs them. Parker's experience building PillPack gives him a direct precedent in making healthcare transactions easier to manage. General Medicine is testing whether that approach can extend beyond prescriptions to the wider chain of care.